Harm Reduction as a Human Right: Shifting the Narrative: A Commentary

This commentary examines harm reduction as a critical yet frequently misunderstood public health approach and argues for its recognition as a fundamental human right grounded in the right to health. It explores how misinformation and punitive drug policies have limited the adoption of evidence-based interventions despite strong global support from international health and human rights bodies. It highlights the effectiveness of harm reduction strategies, including needle and syringe programs, opioid agonist therapy, naloxone distribution, and safer consumption services, in reducing overdose deaths, preventing HIV and hepatitis C transmission, and improving engagement with healthcare systems. By reframing harm reduction as a rights-based obligation rather than a moral debate, this commentary highlights the ethical and legal responsibility of governments to ensure equitable access to lifesaving services. It concludes that integrating harm reduction into national health policies can strengthen public health systems, reduce healthcare costs, and promote dignity and social inclusion for people who use drugs.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-12-31
DOI
https://doi.org/10.5281/zenodo.18333823
Primary Topic
HIV, Drug Use, Sexual Risk
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Harm Reduction as a Human Right: Shifting the Narrative: A Commentary

Maryam Musa
Zenodo (CERN European Organization for Nuclear Research)
HIV, Drug Use, Sexual Risk
article

Harm Reduction as a Human Right: Shifting the Narrative: A Commentary

Maryam Musa
article en

Abstract

This commentary examines harm reduction as a critical yet frequently misunderstood public health approach and argues for its recognition as a fundamental human right grounded in the right to health. It explores how misinformation and punitive drug policies have limited the adoption of evidence-based interventions despite strong global support from international health and human rights bodies. It highlights the effectiveness of harm reduction strategies, including needle and syringe programs, opioid agonist therapy, naloxone distribution, and safer consumption services, in reducing overdose deaths, preventing HIV and hepatitis C transmission, and improving engagement with healthcare systems. By reframing harm reduction as a rights-based obligation rather than a moral debate, this commentary highlights the ethical and legal responsibility of governments to ensure equitable access to lifesaving services. It concludes that integrating harm reduction into national health policies can strengthen public health systems, reduce healthcare costs, and promote dignity and social inclusion for people who use drugs.

Zenodo (CERN European Organization for Nuclear Research)
KentuckyOne Health (US)
Reduced inequalities
Openalex Percentile: Top 27%
HIV, Drug Use, Sexual Risk
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Harm Reduction as a Human Right: Shifting the Narrative: A Commentary — Maryam Musa · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS